pe
pep-05348 v1 CC-BY-SA-4.0

Strongylocin-2 anticancer peptide

A short protein fragment studied in the lab for its ability to fight cancer cells; experimental, not yet an approved drug.

statuscomputed targetANTICANCER length48 aa refs1
anticancer
EARLY ENTRY This candidate is newly indexed — supporting evidence is still being added. Have a paper or data point? Contribute below.
status 2 / 5 · 2 contributors
prediction metrics boltz-2 2.2.1
ipTM0.000
pTM0.293
avg pLDDT48.7
ranking score0.448
STRUCTURE · PEP-05348 × ANTICANCER
ranking0.448
?
RECEPTOR UNKNOWN
peptide conformation only · no target structure
target interface 4.5Å peptide drag rotate · ctrl+scroll zoom · right-click pan
sequence48 aa
15101520253035404548
IFNSIYHRKCVVKNRC ETVSGHKTCKDLTCCR AVIFRHERPEVCRPST
in the news 27 articles
details expand to inspect
full evidence table1 metrics
metricvaluetool
ranking score 0.44847264885902405 boltz-2
3-letter notation
Ile-Phe-Asn-Ser-Ile-Tyr-His-Arg-Lys-Cys-Val-Val-Lys-Asn-Arg-Cys-Glu-Thr-Val-Ser-Gly-His-Lys-Thr-Cys-Lys-Asp-Leu-Thr-Cys-Cys-Arg-Ala-Val-Ile-Phe-Arg-His-Glu-Arg-Pro-Glu-Val-Cys-Arg-Pro-Ser-Thr
recipeboltz-2 2.2.1
parametervalue
modelboltz-2 2.2.1
weights
hardwarevast_v100_32gb
mlx version
python
random seed1
msa strategynone_monomer
runtime
predicted by
predicted at2026-05-23
citationbibtex
peptidemodel (2026). Strongylocin-2 anticancer peptide (pep-05348, v1). PeptideModel. https://peptidemodel.com/card/pep-05348
@peptide{pep05348,
  sequence = {IFNSIYHRKCVVKNRCETVSGHKTCKDLTCCRAVIFRHERPEVCRPST},
  target   = {anticancer},
  author   = {peptidemodel},
  year     = {2026},
  status   = {computed}
}
related peptides 1 by signal overlap
references 1 papers
discussion no comments
sign in to comment
peptidemodel.com CC-BY-SA-4.0 research only · not for human use